Branebrutinib is a compound under investigation in clinical trials, specifically studied for its safety, tolerability, and bioavailability in healthy subjects. It is utilized as a pharmaceutical raw material in research and development settings.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Branebrutinib?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
The international HS code for Branebrutinib (CAS 1912445-55-6) is 2933.39.
2933.39
2933 39 99
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
4-[(3S)-3-(but-2-ynoylamino)piperidin-1-yl]-5-fluoro-2,3-dimethyl-1H-indole-7-carboxamide
VJPPLCNBDLZIFG-ZDUSSCGKSA-N
CC#CC(=O)N[C@H]1CCCN(C1)C2=C(C=C(C3=C2C(=C(N3)C)C)C(=O)N)F
Sourcing Branebrutinib?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.